Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Pimera Therapeutics Logo
Pimera Therapeutics CB Rank
992491
Heat Score
33
Pimera Therapeutics is a clinical-stage biotechnology company that develops PMR-116 and targets Pol I in MYC-driven cancers.
Founded
obfuscation
PrivateGrant San Diego, California, United States1-10 pimeratx.com/
Biotechnology
Clinical Trials
Medical
Overview

Pimera Therapeutics
Heat Score
33

Growth Score
pts
in past quarter
Heat Score 33
-7 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Pimera Therapeutics

CB Rank
992491
Pimera Therapeutics is a clinical-stage biotechnology company that develops PMR-116 and targets Pol I in MYC-driven cancers.
Founded
obfuscation
PrivateGrant San Diego, California, United States1-10 pimeratx.com/
Biotechnology
Clinical Trials
Medical

Funding Rounds

Grant
OBF
in
obfuscation

Key People

Details

Operating Status Active
Company Type For Profit
Founders  Denis Drygin, Mustapha Haddach
About the Company
Pimera Therapeutics is a clinical-stage biotechnology company that focuses on discovering breakthrough therapies for cancer and other important unmet medical needs.
Contact Email info@pimera.com
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Runway Speculation

Products & Services

PMR-116
PMR-116 is a clinical-stage therapeutic agent that inhibits RNA polymerase I to target MYC-driven cancers, including multiple solid tumors.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Pimera Therapeutics Logo
Grant - Pimera Therapeutics
1
obfuscation
Medical Research Future Fund (MRFF)Grant
obfuscation
Grant - Pimera Therapeutics Logo
Grant - Pimera Therapeutics
1
obfuscation
Medical Research Future Fund (MRFF)Grant
obfuscation
Grant - Pimera Therapeutics Logo
Grant - Pimera Therapeutics
1
obfuscation
Medical Research Future Fund (MRFF)Grant
obfuscation
Grant - Pimera Therapeutics Logo
Grant - Pimera Therapeutics
1
obfuscation
Medical Research Future Fund (MRFF)Grant
obfuscation
Grant - Pimera Therapeutics Logo
Grant - Pimera Therapeutics
1
obfuscation
Medical Research Future Fund (MRFF)Grant

Funding Rounds

Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Pimera Therapeutics Logo
Grant - Pimera Therapeutics
1
obfuscation
Medical Research Future Fund (MRFF)Grant
obfuscation
Grant - Pimera Therapeutics Logo
Grant - Pimera Therapeutics
1
obfuscation
Medical Research Future Fund (MRFF)Grant
obfuscation
Grant - Pimera Therapeutics Logo
Grant - Pimera Therapeutics
1
obfuscation
Medical Research Future Fund (MRFF)Grant
obfuscation
Grant - Pimera Therapeutics Logo
Grant - Pimera Therapeutics
1
obfuscation
Medical Research Future Fund (MRFF)Grant
obfuscation
Grant - Pimera Therapeutics Logo
Grant - Pimera Therapeutics
1
obfuscation
Medical Research Future Fund (MRFF)Grant

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 2

Employee Profiles

News
Technology
View Tech Report

IT Spend

$39.8KThis year, Pimera Therapeutics is projected to spend $39.8K on IT, according to Aberdeen.

Active Website Tech Count

4Pimera Therapeutics is actively using 4 technologies for its website, according to BuiltWith. These include CommonCrawl Top 50m, Person Schema, and  Gravatar Profiles.
Sub-Organizations
Frequently Asked Questions

Where is Pimera Therapeutics's headquarters? Pimera Therapeutics is located in San Diego, California, United States.Who invested in Pimera Therapeutics? Pimera Therapeutics is funded by Medical Research Future Fund (MRFF).When was the last funding round for Pimera Therapeutics? Pimera Therapeutics closed its last funding round on
obfuscation
from a Grant round.Who are Pimera Therapeutics's competitors? Alternatives and possible competitors to Pimera Therapeutics may include Novartis, Merck, and  University of Queensland.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(55a1db1 1)
|